Literature DB >> 27479925

Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces.

C Greene1, J Wu1, A H Rickard2, C Xi3.   

Abstract

UNLABELLED: The human opportunistic pathogen, Acinetobacter baumannii, has the propensity to form biofilms and frequently cause medical device-related infections in hospitals. However, the physio-chemical properties of medical surfaces, in addition to bacterial surface properties, will affect colonization and biofilm development. The objective of this study was to compare the ability of A. baumannii to form biofilms on six different materials common to the hospital environment: glass, porcelain, stainless steel, rubber, polycarbonate plastic and polypropylene plastic. Biofilms were developed on material coupons in a CDC biofilm reactor. Biofilms were visualized and quantified using fluorescent staining and imaged using confocal laser scanning microscopy (CLSM) and by direct viable cell counts. Image analysis of CLSM stacks indicated that the mean biomass values for biofilms grown on glass, rubber, porcelain, polypropylene, stainless steel and polycarbonate were 0·04, 0·26, 0·62, 1·00, 2·08 and 2·70 μm(3) /μm(2) respectively. Polycarbonate developed statistically more biofilm mass than glass, rubber, porcelain and polypropylene. Viable cell counts data were in agreement with the CLSM-derived data. In conclusion, polycarbonate was the most accommodating surface for A. baumannii ATCC 17978 to form biofilms while glass was least favourable. Alternatives to polycarbonate for use in medical and dental devices may need to be considered. SIGNIFICANCE AND IMPACT OF THE STUDY: In the hospital environment, Acinetobacter baumannii is one of the most persistent and difficult to control opportunistic pathogens. The persistence of A. baumannii is due, in part, to its ability to colonize surfaces and form biofilms. This study demonstrates that A. baumannii can form biofilms on a variety of different surfaces and develops substantial biofilms on polycarbonate - a thermoplastic material that is often used in the construction of medical devices. The findings highlight the need to further study the in vitro compatibility of medical materials that could be colonized by A. baumannii and allow it to persist in hospital settings.
© 2016 The Society for Applied Microbiology.

Entities:  

Keywords:  Acinetobacter baumannii; Biofilms; environment; environmental surfaces; infection control; medical device

Mesh:

Substances:

Year:  2016        PMID: 27479925      PMCID: PMC7057210          DOI: 10.1111/lam.12627

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  29 in total

Review 1.  The biofilm matrix--an immobilized but dynamic microbial environment.

Authors:  I W Sutherland
Journal:  Trends Microbiol       Date:  2001-05       Impact factor: 17.079

2.  Quantification of biofilm structures by the novel computer program COMSTAT.

Authors:  A Heydorn; A T Nielsen; M Hentzer; C Sternberg; M Givskov; B K Ersbøll; S Molin
Journal:  Microbiology       Date:  2000-10       Impact factor: 2.777

Review 3.  Biofilms as complex differentiated communities.

Authors:  P Stoodley; K Sauer; D G Davies; J W Costerton
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

4.  Transition between superhydrophobic states on rough surfaces.

Authors:  Neelesh A Patankar
Journal:  Langmuir       Date:  2004-08-17       Impact factor: 3.882

5.  Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters.

Authors:  Nadia Kazemi Pour; Devendra H Dusane; Prashant K Dhakephalkar; Farokh Rokhbakhsh Zamin; Smita S Zinjarde; Balu A Chopade
Journal:  FEMS Immunol Med Microbiol       Date:  2011-06-28

6.  Biofilm formation by Acinetobacter baumannii.

Authors:  R Vidal; M Dominguez; H Urrutia; H Bello; G Gonzalez; A Garcia; R Zemelman
Journal:  Microbios       Date:  1996

7.  Ceramic-on-ceramic total hip arthroplasty: incidence of instability and noise.

Authors:  David Schroder; Lindsey Bornstein; Mathias P G Bostrom; Bryan J Nestor; Douglas E Padgett; Geoffrey H Westrich
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

Review 8.  Acinetobacter: an old friend, but a new enemy.

Authors:  K J Towner
Journal:  J Hosp Infect       Date:  2009-08-22       Impact factor: 3.926

9.  Effect of a ventilator-focused intervention on the rate of Acinetobacter baumannii infection among ventilated patients.

Authors:  Regev Cohen; Zvi Shimoni; Riad Ghara; Ron Ram; Ronen Ben-Ami
Journal:  Am J Infect Control       Date:  2014-09       Impact factor: 2.918

10.  Evaluation of composite mesh for ventral hernia repair.

Authors:  Jim F Byrd; Neal Agee; Phuong H Nguyen; Jessica J Heath; Kwan N Lau; Iain H McKillop; David Sindram; John B Martinie; David A Iannitti
Journal:  JSLS       Date:  2011 Jul-Sep       Impact factor: 2.172

View more
  17 in total

1.  The structure of PilA from Acinetobacter baumannii AB5075 suggests a mechanism for functional specialization in Acinetobacter type IV pili.

Authors:  Leslie A Ronish; Erik Lillehoj; James K Fields; Eric J Sundberg; Kurt H Piepenbrink
Journal:  J Biol Chem       Date:  2018-11-09       Impact factor: 5.157

2.  Molecular Study of Acinetobacter baumannii that Lacking Some Essentials Genes Responsible of Toxin-Antitoxin System.

Authors:  A Hussein Almola; A W Al-Omari; A Younis Mahdy Al-Hamadany
Journal:  Arch Razi Inst       Date:  2022-02-01

3.  Whole-Genome Sequencing of a Colistin-Resistant Acinetobacter baumannii Strain Isolated at a Tertiary Health Facility in Pretoria, South Africa.

Authors:  Noel-David Nogbou; Mbudzeni Ramashia; Granny Marumo Nkawane; Mushal Allam; Chikwelu Lawrence Obi; Andrew Munyalo Musyoki
Journal:  Antibiotics (Basel)       Date:  2022-04-28

Review 4.  Uncovering the mechanisms of Acinetobacter baumannii virulence.

Authors:  Christian M Harding; Seth W Hennon; Mario F Feldman
Journal:  Nat Rev Microbiol       Date:  2017-12-18       Impact factor: 60.633

Review 5.  Spatial Organization Plasticity as an Adaptive Driver of Surface Microbial Communities.

Authors:  Arnaud Bridier; Jean-Christophe Piard; Caroline Pandin; Simon Labarthe; Florence Dubois-Brissonnet; Romain Briandet
Journal:  Front Microbiol       Date:  2017-07-20       Impact factor: 5.640

6.  Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico.

Authors:  Roberto Rosales-Reyes; Catalina Gayosso-Vázquez; José Luis Fernández-Vázquez; Ma Dolores Jarillo-Quijada; César Rivera-Benítez; José Ignacio Santos-Preciado; María Dolores Alcántar-Curiel
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 7.  Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments.

Authors:  Emmanuel C Eze; Hafizah Y Chenia; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

Review 8.  Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis.

Authors:  Jennifer M Colquhoun; Philip N Rather
Journal:  Front Cell Infect Microbiol       Date:  2020-05-29       Impact factor: 5.293

9.  Pan-Drug Resistant Acinetobacter baumannii, but Not Other Strains, Are Resistant to the Bee Venom Peptide Mellitin.

Authors:  Rangel Karyne; Guilherme Curty Lechuga; André Luis Almeida Souza; João Pedro Rangel da Silva Carvalho; Maria Helena Simões Villas Bôas; Salvatore Giovanni De Simone
Journal:  Antibiotics (Basel)       Date:  2020-04-14

10.  Phenotypic and Genotypic Characteristics of Biofilm Formation in Clinical Isolates of Acinetobacter baumannii.

Authors:  Zhaoyinqian Li; Zixuan Ding; Yao Liu; Xinrui Jin; Jingling Xie; Tingting Li; Zhangrui Zeng; Zhibin Wang; Jinbo Liu
Journal:  Infect Drug Resist       Date:  2021-07-07       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.